The Trump administration is considering a five-year pilot program to cover weight-loss drugs under Medicare and Medicaid, the ...

The Trump administration is planning an experiment to cover weight loss drugs under Medicare and Medicaid, potentially ...

The federal government is expected to start a 5-year-long experiment that will provide some limited coverage of obesity ...

U.S. President Donald Trump listens to remarks during a swearing-in ceremony for Administrator of the Centers for Medicare ...

The Trump administration is planning an experiment to cover weight-loss drugs under Medicare and Medicaid, the Washington ...

Changes to Medicaid could leave thousands of South Dakotans uninsured and impair an already fragile rural health care system, ...

Throughout the country, pediatricians say anxious parents are concerned about access to routine childhood immunizations, ...

As changes to Medicaid funding and enrollment requirements come into effect over the next few years, the Minnesota Department ...

A new state analysis found that up to 140,000 Minnesotans could lose health care coverage due to federal Medicaid spending ...

Medicare and Medicaid could expand coverage of GLP-1 drugs, such as Ozempic and Wegovy, and pay for patients’ use of the ...

A five-year experiment aims to open access to blockbuster GLP‑1 drugs for obesity, something advocates have pushed for years.

Blockbuster weight loss drugs like Wegovy and Zepbound have surged in popularity, but high prices have left them out of reach for many obese Americans.